Paid Clinical Trials in Scarborough, ME
As of September 2026, 93 paid clinical trials are recruiting in Scarborough, Maine. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Scarborough offers studies at sites including MaineHealth Maine Medical Center- Scarborough for conditions such as Acute Myeloid Leukemia, Breast Cancer, Malignant Solid Neoplasm, Ovarian Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Scarborough
Trials by drug in Scarborough
Filter results
90 clinical trials
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Nectero EAST System Clinical Study
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Endometrial Cancer Vaginal Fluid Specimen Collection Study
Clinical Outcome Measure at Stryker Spine
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Top Research Study Locations in Scarborough
Researchers run research studies in Scarborough, ME at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MaineHealth Maine Medical Center- Scarborough | Acute Myeloid Leukemia, Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm | 39 |
| Maine Children's Cancer Program | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular | 25 |
| New England Cancer Specialists | Breast Cancer, HER2-positive Breast Cancer, Chronic Lymphocytic Leukemia | 5 |
| Maine Medical Center - Scarborough Campus | Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms | 3 |
| MaineHealth | Abnormal Uterine Bleeding (AUB), Atypical Endometrial Hyperplasia, Endometrial Cancer | 2 |
| Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer | 2 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 1 |
| Local Institution - 0127 | Metastatic Non-small Cell Lung Cancer With MTAP Deletion | 1 |
| MMP Neurology | Focal Epilepsy, Tonic-Clonic Seizures | 1 |
| Maine Center For Cancer Medicine | Ovarian Cancer | 1 |
| Maine Health Cardiology | Cardiovascular Disease and Lipoprotein(a) | 1 |
| Maine Hemophilia and Thrombosis Center | Bleeding Disorder, Connective Tissue Disorder, Factor IX Deficiency | 1 |
| Maine Medical Center | Locally Advanced Solid Tumors, Lymphoma, Metastatic Solid Tumors | 1 |
| Maine Medical Center- Scarborough Campus | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
| Maine Medical Partner's Women's Health | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma | 1 |
| Maine Medical Partners MaineHealth Cardiology | Atrial Fibrillation | 1 |
| Maine Medical Partners-Woman's Health-Division of Gynecologic Oncology | Cervical Cancer | 1 |
| MaineHealth Cancer Care | Extensive Stage Small Cell Lung Cancer (ES-SCLC) | 1 |
| MaineHealth Cancer Care - Scarborough | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| MaineHealth Cancer Care and Blood Disorders Scarborough | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| MaineHealth Cardiology | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| MaineHealth Center for Clinical and Translational Science | Drug Effect, Musculoskeletal Abnormalities, Obesity | 1 |
| MaineHealth Neurosurgery and Spine | Degenerative Disc Disease, Degenerative Scoliosis | 1 |
| MaineHealth Pediatric Neurology | Headache, Migraine | 1 |
| MaineMed Vascular Surgery | Abdominal Aortic Aneurysm | 1 |
Active & Upcoming Studies in Scarborough (2026)
Recruiting trials in Scarborough grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (65 active studies)
- A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment · Phase 2 · Alliance for Clinical Trials in Oncology
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · Children's Oncology Group
Diabetes & metabolic (2 active studies)
- GLP-1R Actions on Muscle and the Skeleton · Phase 4 · Pennington Biomedical Research Center
- A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma · Phase 2 · Children's Oncology Group
Neurology & pain (2 active studies)
- Adolescent Lifestyle Medicine Headache Study · MaineHealth
- An Open-label Study of XEN1101 in Epilepsy · Phase 3 · Xenon Pharmaceuticals Inc.
Vaccines (1 active study)
Cardiovascular (1 active study)
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation · Phase 3 · Johns Hopkins University
Common conditions studied in Scarborough
- Acute Myeloid Leukemia (9 active studies)
- Breast Cancer (5 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Ovarian Cancer (5 active studies)
- Endometrial Cancer (4 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
Leading research sponsors in Scarborough
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Wake Forest University Health Sciences
Frequently asked questions
How many paid clinical trials are currently recruiting in Scarborough?
There are approximately 93 recruiting clinical trials in Scarborough, Maine listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Scarborough pay participants?
Most recruiting trials in Scarborough compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Scarborough?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Scarborough?
The most common conditions under active study in Scarborough include Acute Myeloid Leukemia (9), Breast Cancer (5), Malignant Solid Neoplasm (5), Ovarian Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Scarborough?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Scarborough on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Scarborough?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Scarborough?
Recruiting research sites in Scarborough include MaineHealth Maine Medical Center- Scarborough, Maine Children's Cancer Program, New England Cancer Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Scarborough right now?
The largest active categories in Scarborough are Cancer & tumors (65), Diabetes & metabolic (2), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.